{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F1162023-confirming-VkRKUuLD","width":444,"version":"1.0","type":"rich","title":"11.6.2023 - Confirming","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/75ac080c-5f93-42de-a8de-dc5ef3b807d3\" height=\"200\" width=\"100%\" title=\"11.6.2023 - Confirming\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out this week's QuadCast as we highlight TNT with chemoradiation to reduce the need for surgery on the OPRA trial, the safety of a laparoscopic Whipple, the dangers of HER2-targeted agents during pregnancy, and more."}